glp 1 and eating disorders GLP-1 Medications Disorders: Risks, Benefits & Mental Health Support Tips for prescribing GLP-1s in
Description
[Crossref] [PubMed] Aronne LJ, Sattar N, Horn DB, et al

[DOI] [PubMed] [Google Scholar] 52.Yamada Y., Katagiri H., Hamamoto Y., Deenadayalan S., Navarria A., Nishijima K., Seino Y., PIONEER 9 Investigators Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): A 52-week, phase 2/3a, randomised, controlled trial
Researchers found an association between the use of GLP-1s and a higher risk for the condition, called ischemic optic neuropathy, although the risk remained low

They are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
Fatigue and Dizziness General weakness, dizziness, and loss of energy are frequently reported, particularly during early dose titration
Without that clinical context, its easy for associations to be made that arent necessarily causal
